This Biotech Stock Plunged 20% but Wall Street Expects a 195% Recovery
24/7 Wall St.With the pandemic largely in the rear-view mirror, COVID-19 vaccine winner Novavax has seen shares fall. Yet, analysts have high hopes for the stock.
The post This Biotech Stock Plunged 20% but Wall Street Expects a 195% Recovery appeared first on 24/7 Wall St..